Acceleron Pharma (XLRN) Stock Price, Quote, News and Overview

What is the stock price of Acceleron Pharma today?

The current stock price of XLRN is 178.75 null. The price decreased by -0.52% in the last trading session.

What is the ticker symbol for Acceleron Pharma stock?

The exchange symbol of Acceleron Pharma is XLRN and it is listed on the Nasdaq exchange.

On which exchange is XLRN stock listed?

XLRN stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for Acceleron Pharma stock?

17 analysts have analysed XLRN and the average price target is 182.68 null. This implies a price increase of 2.2% is expected in the next year compared to the current price of 178.75. Check the Acceleron Pharma stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Acceleron Pharma worth?

Acceleron Pharma (XLRN) has a market capitalization of 10.89B null. This makes XLRN a Large Cap stock.

How many employees does Acceleron Pharma have?

Acceleron Pharma (XLRN) currently has 312 employees.

What are the support and resistance levels for Acceleron Pharma (XLRN) stock?

Acceleron Pharma (XLRN) has a support level at 175.27 and a resistance level at 182.79. Check the full technical report for a detailed analysis of XLRN support and resistance levels.

Is Acceleron Pharma (XLRN) expected to grow?

The Revenue of Acceleron Pharma (XLRN) is expected to grow by 41.05% in the next year. Check the estimates tab for more information on the XLRN EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Acceleron Pharma (XLRN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of XLRN, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of XLRN, evaluating the profitability, health, valuation and growth aspects
• Acceleron Pharma (XLRN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Acceleron Pharma (XLRN) Sales and EPS estimates to see what analysts future expectations are.
• Acceleron Pharma (XLRN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Acceleron Pharma (XLRN) Insider and Institutional Ownership to learn about the owners and their transactions.
• Acceleron Pharma (XLRN) Stock Chart to make your own analysis
• Acceleron Pharma (XLRN) Latest news and press-releases to stay up to date.

Does Acceleron Pharma (XLRN) stock pay dividends?

XLRN does not pay a dividend.

When does Acceleron Pharma (XLRN) report earnings?

Acceleron Pharma (XLRN) will report earnings on 2022-02-28, after the market close.

What is the Price/Earnings (PE) ratio of Acceleron Pharma (XLRN)?

Acceleron Pharma (XLRN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.21).

ChartMill assigns a fundamental rating of 3 / 10 to XLRN. While XLRN seems to be doing ok healthwise, there are quite some concerns on its profitability.

Over the last trailing twelve months XLRN reported a non-GAAP Earnings per Share(EPS) of -4.21. The EPS decreased by -76.15% compared to the year before.

ChartMill assigns a Buy % Consensus number of 73% to XLRN. The Buy consensus is the average rating of analysts ratings from 17 analysts.

For the next year, analysts expect an EPS growth of -41.56% and a revenue growth 41.05% for XLRN